Stay updated on Ibrutinib Combo in Metastatic Pancreatic Adeno Clinical Trial

Sign up to get notified when there's something new on the Ibrutinib Combo in Metastatic Pancreatic Adeno Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ibrutinib Combo in Metastatic Pancreatic Adeno Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page revision updates from v3.4.1 to v3.4.2 and does not affect study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T07:54:20.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision label on the page changed from v3.4.0 to v3.4.1. No visible changes to study content or functionality were observed.
    Difference
    0.1%
    Check dated 2026-02-06T00:02:04.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Revision: v3.3.4 is now displayed, replacing the previous revision v3.3.3.
    Difference
    0.0%
    Check dated 2026-01-15T04:59:01.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    The study's Locations section was updated: numerous new sites were added across the United States and internationally (including Belgium, France, Germany, Korea, Spain, and the United Kingdom) and several existing sites were removed, expanding and reorganizing where the trial is conducted.
    Difference
    3%
    Check dated 2025-12-24T16:44:21.000Z thumbnail image
  6. Check
    92 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2; no visible changes to the study details content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T16:52:53.000Z thumbnail image
  7. Check
    99 days ago
    Change Detected
    Summary
    The government funding and NIH operating status notice was removed from the page; core trial details such as study plan, locations, and eligibility remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-17T15:03:11.000Z thumbnail image

Stay in the know with updates to Ibrutinib Combo in Metastatic Pancreatic Adeno Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ibrutinib Combo in Metastatic Pancreatic Adeno Clinical Trial page.